staurosporine has been researched along with Heart Failure in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 6 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (11.11) | 2.80 |
| Authors | Studies |
|---|---|
| Liang, C; Luo, Y; Tian, L; Xu, Y | 1 |
| Angelini, A; Calvani, M; Dalla Libera, L; Della Barbera, M; Dona, M; Gobbo, V; Mosconi, L; Peluso, G; Ravara, B; Sandri, M; Vescovo, G | 1 |
| Fauconnier, J; Lacampagne, A; Rauzier, JM; Richard, S; Vassort, G | 1 |
| Chen, K; Chen, SR; Cheng, H; Obayashi, M; Shimoni, Y; Ter Keurs, H; Walsh, MP; Xiao, B; Yang, D; Zhong, G | 1 |
| Bers, DM | 1 |
| Konhilas, JP | 1 |
| Cangemi, R; Carnevale, R; Celestini, A; Ferro, D; Loffredo, L; Martini, A; Pignatelli, P; Polimeni, L; Violi, F | 1 |
| Bélichard, P; Calderone, A; de Champlain, J; Rouleau, JL; Stewart, DJ | 1 |
| Cheng, CP; Little, WC; Ohte, N; Suzuki, M; Wang, ZM; Williams, DL | 1 |
9 other study(ies) available for staurosporine and Heart Failure
| Article | Year |
|---|---|
KLHL38 facilitates staurosporine-induced apoptosis in HL-1 cells via myocardin degradation.
Topics: Animals; Apoptosis; Heart Failure; Humans; Mice; Nuclear Proteins; Staurosporine; Trans-Activators | 2022 |
L-Carnitine: a potential treatment for blocking apoptosis and preventing skeletal muscle myopathy in heart failure.
Topics: Angiotensin II; Animals; Apoptosis; Carnitine; Caspase 3; Caspase 9; Caspases; Cell Nucleus; Cells, Cultured; Cytoprotection; Disease Models, Animal; Disease Progression; Drug Evaluation, Preclinical; Glucose Transporter Type 4; Heart Failure; In Situ Nick-End Labeling; Liver Function Tests; Male; Monocrotaline; Monosaccharide Transport Proteins; Muscle Proteins; Muscle, Skeletal; Muscular Disorders, Atrophic; Myosin Heavy Chains; Protein Isoforms; Rats; Rats, Sprague-Dawley; Sphingolipids; Staurosporine; Tumor Necrosis Factor-alpha | 2002 |
Ca2+-dependent reduction of IK1 in rat ventricular cells: a novel paradigm for arrhythmia in heart failure?
Topics: Action Potentials; Animals; Arrhythmias, Cardiac; Calcium; Depression, Chemical; Egtazic Acid; Heart Failure; Immunosuppressive Agents; Male; Myocardial Infarction; Myocardium; Patch-Clamp Techniques; Potassium Channels, Inwardly Rectifying; Protein Kinase C; Rats; Rats, Wistar; Ryanodine; Ryanodine Receptor Calcium Release Channel; Sirolimus; Staurosporine; Tacrolimus | 2005 |
Ser-2030, but not Ser-2808, is the major phosphorylation site in cardiac ryanodine receptors responding to protein kinase A activation upon beta-adrenergic stimulation in normal and failing hearts.
Topics: Adrenergic beta-Agonists; Animals; Arrhythmias, Cardiac; Benzylamines; Blotting, Western; Calcium Signaling; Carrier Proteins; Cell Line; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Humans; Ion Channel Gating; Ion Transport; Isoproterenol; Kidney; Marine Toxins; Mice; Myocytes, Cardiac; Oxazoles; Peptide Fragments; Phosphoprotein Phosphatases; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rabbits; Rats; Recombinant Fusion Proteins; Ryanodine Receptor Calcium Release Channel; Sodium-Calcium Exchanger; Staurosporine; Structure-Activity Relationship; Sulfonamides; Transfection | 2006 |
Cardiac ryanodine receptor phosphorylation: target sites and functional consequences.
Topics: Adrenergic beta-Agonists; Animals; Calcium; Calcium Signaling; Calcium-Calmodulin-Dependent Protein Kinase Type 2; Calcium-Calmodulin-Dependent Protein Kinases; Cyclic AMP-Dependent Protein Kinases; Heart Failure; Humans; Mice; Myocytes, Cardiac; Phosphorylation; Phosphoserine; Protein Processing, Post-Translational; Protein Serine-Threonine Kinases; Rabbits; Rats; Ryanodine Receptor Calcium Release Channel; Sarcolemma; Sodium-Calcium Exchanger; Staurosporine | 2006 |
What makes a dead cell attractive?
Topics: Animals; Apoptosis; Cell Movement; Chemokine CCL2; Disease Models, Animal; Dose-Response Relationship, Drug; Heart Failure; Humans; Macrophages; Monocytes; Myocardial Reperfusion Injury; Myocytes, Cardiac; Paracrine Communication; Staurosporine; Up-Regulation | 2008 |
Tumour necrosis factor alpha upregulates platelet CD40L in patients with heart failure.
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetophenones; Aged; Aged, 80 and over; Arachidonic Acids; Aspirin; Blood Platelets; Case-Control Studies; CD40 Ligand; Cyclooxygenase 1; Deoxyguanosine; Enzyme Inhibitors; Female; Heart Failure; Humans; Male; Middle Aged; NADPH Oxidases; Oxidative Stress; Phospholipase A2 Inhibitors; Phospholipases A2; Protein Kinase C; Receptors, Tumor Necrosis Factor; Severity of Illness Index; Signal Transduction; Staurosporine; Tumor Necrosis Factor-alpha; Up-Regulation | 2008 |
Regulation of the endothelin-1 transmembrane signaling pathway: the potential role of agonist-induced desensitization in the coronary artery of the rapid ventricular pacing-overdrive dog model of heart failure.
Topics: Alkaloids; Animals; Arteries; Coronary Vessels; Disease Models, Animal; Dogs; Endothelins; Heart Failure; In Vitro Techniques; Inositol Phosphates; Phosphatidylinositols; Protein Kinase C; Radioimmunoassay; Receptors, Endothelin; Second Messenger Systems; Signal Transduction; Staurosporine; Tetradecanoylphorbol Acetate; Type C Phospholipases | 1993 |
Altered inotropic response of endothelin-1 in cardiomyocytes from rats with isoproterenol-induced cardiomyopathy.
Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Amiloride; Animals; Anti-Arrhythmia Agents; Calcium; Cardiotonic Agents; Cell Size; Cells, Cultured; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Heart Failure; Hemodynamics; Isoproterenol; Male; Myocardial Contraction; Myocardium; Peptides, Cyclic; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptors, Endothelin; Sodium-Hydrogen Exchangers; Staurosporine | 1998 |